INR
GBP
CNY
EUR
JPY
MYR
ZAR
KRW
THB
USD
US Clinical Decision Support System (CDSS) Growth Opportunities
US Clinical Decision Support System (CDSS) Growth Opportunities
Sparking Future Growth Potential for Health Data, AI, and SDoH to Increase Accuracy and Efficiency among Providers and Payers and Improve the Patient Journey
08-Mar-2022
North America
Market Research
₹413,173.53
Special Price ₹309,880.15 save 25 %
Description
Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert. It includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that must include electronic health records (EHRs) and be maintained by an IT platform.
This report reviews the growth opportunities that are driving the US CDSS market. It provides the current market segmentation that includes a mix of established content-based solutions and technical companies that are attracted to the CDSS space. The 4 segments covered are decision evidence and protocols, decision workflow, decision analytics, and decision delivery.
Research Scope
For the purpose of this study, Frost & Sullivan has mapped and forecasted clinical decision support systems based on a mix of evidence (content), analytics, workflow, and point-of-care (POC) solutions. The study attempts to focus specifically on solutions that have a visible presence within the CDSS space. A number of start-ups are building new solutions that have earned minimal revenue, but some of these companies will be listed. Also, the study includes examples of companies that are outside of the CDSS market but offer adjacent data inputs and solutions that add value to a CDSS. The revenue estimates focus only on revenue attributed to CDSS. In some cases, such as analytics, EHR, or medical device companies, CDSS revenue represents a small part of a larger revenue stream. The study period is 2021–2026 with forecasts covering 2022–2026.
Table of Contents
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the US CDSS Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Executive Summary
Scope of Analysis
Segmentation
Key Growth Metrics
Key Competitors
Growth Drivers
Growth Driver Analysis
Growth Driver Analysis (continued)
Growth Restraints
Growth Restraint Analysis
Growth Restraint Analysis (continued)
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Application
Revenue Forecast Analysis
Competitive Environment
CDSS Market—Mergers & Acquisitions
CDSS Market—Mergers & Acquisitions (continued)
Key Growth Metrics
Revenue Forecast
Revenue Forecast Analysis
Key Growth Metrics
Revenue Forecast
Forecast Analysis
Key Growth Metrics
Revenue Forecast
Forecast Analysis
Key Growth Metrics
Revenue Forecast
Forecast Analysis
Case Study—Change Healthcare, a Payer/Provider Ecosystem
Case Study—Wolters Kluwer, Building an End-to-End Solution in a Patient-centric Model
Growth Opportunity 1—Develop Disease-specific CDS Algorithms to Help Avoid Need for ICU Admission or Re-admission for Patients with Chronic Conditions
Growth Opportunity 1—Develop Disease-specific CDS Algorithms to Help Avoid Need for ICU Admission or Re-admission for Patients with Chronic Conditions (continued)
Growth Opportunity 2—Incorporate Updated, Peer-reviewed, and Actionable Evidence to Support Long-term Rehabilitation Post Surgery
Growth Opportunity 2—Incorporate Updated, Peer-reviewed, and Actionable Evidence to Support Long-term Rehabilitation Post Surgery (continued)
Growth Opportunity 3—Establish Omni-channel CDS through a Platform-as-a-Service Capability to Reduce the Burden of Antibiotics
Growth Opportunity 3—Establish Omni-channel CDS through a Platform-as-a-Service Capability to Reduce the Burden of Antibiotics (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
Popular Topics
Research Scope
For the purpose of this study, Frost & Sullivan has mapped and forecasted clinical decision support systems based on a mix of evidence (content), analytics, workflow, and point-of-care (POC) solutions. The study attempts to focus specifically on solutions that have a visible presence within the CDSS space. A number of start-ups are building new solutions that have earned minimal revenue, but some of these companies will be listed. Also, the study includes examples of companies that are outside of the CDSS market but offer adjacent data inputs and solutions that add value to a CDSS. The revenue estimates focus only on revenue attributed to CDSS. In some cases, such as analytics, EHR, or medical device companies, CDSS revenue represents a small part of a larger revenue stream. The study period is 2021–2026 with forecasts covering 2022–2026.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Delfina Huergo |
| Industries | Healthcare |
| WIP Number | K711-01-00-00-00 |
| Keyword 1 | CDSS |
| Keyword 2 | Clinical decision support (CDS) |
| Keyword 3 | electronic health records (EHRs) |
| Is Prebook | No |
| GPS Codes | 9564-B1,9600-B1,9612-B1 |